Medicus Pharma Ltd.
Price Action
Technical Summary
WEAKENINGMedicus Pharma Ltd. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 36), showing significant lag compared to the market leaders. Earnings growth of 48% provides fundamental context to the price action. Investors should exercise caution due to high volatility (376% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $0.43 | +16.22% | ABOVE |
| 50 SMA | $0.44 | +12.07% | ABOVE |
| 100 SMA | $0.73 | -32.01% | BELOW |
| 150 SMA | $0.96 | -48.29% | BELOW |
| 200 SMA | $0.97 | -48.85% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is MDCXW in an uptrend right now?
MDCXW has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.
Is MDCXW overbought or oversold?
MDCXW's RSI (14) is 49. The stock is in neutral territory, neither overbought nor oversold.
Is MDCXW outperforming the market?
MDCXW has a Relative Strength (RS) Rating of 36 out of 99. MDCXW is currently lagging the broader market.
Where is MDCXW in its 52-week range?
MDCXW is trading at $0.49, which is 20% of its 52-week high ($2.50) and 12% above its 52-week low ($0.21).
How volatile is MDCXW?
MDCXW has a Beta of 0.27 and 52-week volatility of 376%. It's less volatile than the S&P 500 - generally more stable.